Prosecution Insights
Last updated: October 02, 2026

Examiner: ELSHAER, ALAAELDIN M

Tech Center 3600 • Art Units: 1631 3626 3683 3686 3687

This examiner grants 36% of resolved cases

Analysis

Alaaeldin M. Elshaer, working in Tech Center 3600 and Art Unit 1631, has handled 219 resolved cases. The allowance rate of 36.1 percent is relatively low, indicating a difficult environment for securing patent grants. Applicants should also expect the prosecution period to reach a median of 1155 days to allowance. These metrics suggest that the examiner maintains a high bar for patentability and requires thorough documentation and argumentation in Art Unit 1631.

However, the interview lift of 30.5 percent is very high. This suggests that while the 36.1 percent allowance rate is low, an interview is a powerful tool for changing the outcome of a case. Practitioners facing rejections from this examiner should strongly consider scheduling an interview, as the 30.5 percent lift significantly improves the chances of moving toward an allowance. The disparity between the grant rate and the high interview lift highlights the importance of direct communication in navigating the complexities of this specific docket.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

36.1%
Allow Rate
-15.9% vs TC avg
265
Total Applications
+30.5%
Interview Lift
1155
Avg Prosecution Days
Based on 219 resolved cases, 2023–2026

Rejection Statute Breakdown

37.6%
§101 Eligibility
6.5%
§102 Novelty
38.6%
§103 Obviousness
13.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19054773 BIOLOGICAL AGE DETERMINATION USING A WEARABLE DEVICE Non-Final OA Apple Inc.
18891812 HEALTH FUTURE PROJECTOR Non-Final OA Toyota Research Institute, Inc.
19172554 MEDICAL SERVICE SUPPORT DEVICE, MEDICAL SERVICE SUPPORT METHOD, AND MEDICAL SERVICE SUPPORT PROGRAM Final Rejection FUJIFILM Corporation
19285592 SYSTEMS AND METHODS FOR USING SMART EXERCISE DEVICES TO PERFORM CARDIOVASCULAR REHABILITATION Non-Final OA ROM TECHNOLOGIES, INC.
18093843 SYSTEM AND METHOD TO COMBINE MULTIPLE PREDICTIVE OUTPUTS TO PREDICT COMPREHENSIVE AKI RISK Non-Final OA KONINKLIJKE PHILIPS N.V.
17848552 SYSTEMS AND METHODS FOR MODELLING A HUMAN SUBJECT Final Rejection KONINKLIJKE PHILIPS N.V.
19112143 MACHINE LEARNING SYSTEMS AND RELATED ASPECTS FOR THE DETECTION OF DISEASE STATES Final Rejection THE JOHNS HOPKINS UNIVERSITY
18157905 SUBSCRIPTION AND RETRIEVAL OF MEDICAL IMAGING DATA Final Rejection Siemens Healthcare GmbH
19109553 Systems and Methods for Generating Protocols Embodying Contrast and Radiation Dose Management Techniques Final Rejection BAYER HEALTHCARE LLC
19311004 SUGGESTION SYSTEM Non-Final OA TOPCON CORPORATION
17819288 METHODS AND SYSTEMS FOR TREATMENT GUIDELINE DISPLAY Final Rejection GE Precision Healthcare LLC
17164602 SYSTEMS AND METHODS FOR GENERATING A NUTRITIVE PLAN TO MANAGE A UROLOGICAL DISORDER Final Rejection KPN INNOVATIONS, LLC.
19217577 SMART BARCODE ID FOR INTEROPERABLE PUMPS Final Rejection CareFusion 303, Inc.
18873099 A CLINICAL DECISION SUPPORT TOOL AND METHOD FOR PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION Non-Final OA Carnegie Mellon University
19233384 SYSTEM Non-Final OA SYSMEX CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month